Hemogenyx Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	49	35	14	26	13	18
Market Cap Growth	508.02%	143.47%	-45.35%	99.30%	-29.25%	-55.98%
Enterprise Value	49.8	34.92	16.61	27.63	13.89	11.56
Last Close Price	7.27	5.72	4.05	9.20	5.32	7.52
PB Ratio	43.19	28.91	15.81	9.21	3.98	2.25
P/TBV Ratio	31.87	25.08	31.83	11.06	4.60	1.88
Debt / Equity Ratio	1.36	1.36	2.58	0.93	0.96	0
Net Debt / Equity Ratio	0.35	0.35	2.75	0.60	0.27	-0.83
Net Debt / EBITDA Ratio	-0.06	-0.06	-0.52	-0.29	-0.23	2.65
Net Debt / FCF Ratio	-0.12	-0.12	-0.59	-0.27	-0.27	2.09
Quick Ratio	1.38	1.38	0.72	2.93	3.47	20.23
Current Ratio	1.38	1.38	0.72	2.93	3.47	20.23
Return on Equity (ROE)	-977.72%	-977.72%	-309.56%	-222.31%	-69.88%	-112.98%
Return on Assets (ROA)	-166.44%	-166.44%	-104.23%	-97.98%	-51.21%	-48.33%
Return on Invested Capital (ROIC)	-446.79%	-286.10%	-137.93%	-150.14%	-146.15%	-266.51%
Return on Capital Employed (ROCE)	-242.40%	-242.40%	-127.76%	-110.45%	-55.09%	-59.71%
Buyback Yield / Dilution	-34.57%	-34.57%	-16.95%	-15.25%	-26.59%	-86.57%
Total Shareholder Return	-34.57%	-34.57%	-16.95%	-15.25%	-26.59%	-86.57%